Extended anticoagulation for unprovoked venous thromboembolism

After completing anticoagulation therapy for acute venous thromboembolism (VTE), patients with unprovoked VTE are at increased risk of recurrent thrombotic events. Recent studies suggest a risk of nearly 10% in the first year after stopping anticoagulants and 30% at 8 years. Therefore, it is importa...

Descripción completa

Detalles Bibliográficos
Autores principales: Castellucci, Lana A., de Wit, Kerstin, Garcia, David, Ortel, Thomas L., Le Gal, Grégoire
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Online‐only Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6046599/
https://www.ncbi.nlm.nih.gov/pubmed/30046758
http://dx.doi.org/10.1002/rth2.12121

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6046599/
https://www.ncbi.nlm.nih.gov/pubmed/30046758
http://dx.doi.org/10.1002/rth2.12121

Ejemplares similares